Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

Abstract

This observational study revealed that the addition of the NMDA receptor antagonist memantine to the treatment of AD with ChEI significantly altered the treated history of AD by extending time to nursing home admission.